成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

FABACEIN

FABACEIN Struktur
37710-13-7
CAS-Nr.
37710-13-7
Englisch Name:
FABACEIN
Synonyma:
FABACEIN;(10α,23E)-16α,25-Diacetoxy-2β,20-dihydroxy-9β-methyl-19-norlanosta-5,23-diene-3,11,22-trione;19-Norlanosta-5,23-diene-3,11,22-trione, 16,25-bis(acetyloxy)-2,20-dihydroxy-9-methyl-, (2β,9β,10α,16α,23E)-;19-Norlanosta-5,23-diene-3,11,22-trione, 16,25-bis(acetyloxy)-2,20-dihydroxy-9-methyl-, (2β,9β,10α,16α,23E)- (9CI)
CBNumber:
CB61247778
Summenformel:
C34H48O9
Molgewicht:
600.74
MOL-Datei:
37710-13-7.mol

FABACEIN Eigenschaften

Schmelzpunkt:
178-179 °C
Siedepunkt:
703.6±60.0 °C(Predicted)
Dichte
1.22±0.1 g/cm3(Predicted)
pka
12.60±0.29(Predicted)

Sicherheit

FABACEIN Chemische Eigenschaften,Einsatz,Produktion Methoden

FABACEIN Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

FABACEIN Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aktin Chemicals, Inc. 		028-85159085
info@aktinchem.com CHINA 1025 58
Wuhan ChemFaces Biochemical Co., Ltd. 18607101326 15172504745
 aileen@chemfaces.com China 6905 55
Chongqing Chemieliva Pharmaceutical Co., Ltd. 023-67770219
jessica.hu@chemieliva.com China 1469 60
Nanjing Digger Medical Technology Co. Ltd. 025-025-51191215 18013836722
 2399235533@qq.com China 4933 58
Aktin Chemicals, Inc. 028-85159085
info@aktinchem.com China 1769 58
Shanghai Moqi Biological Technology Co., LTD 021-38218169 13341702378
 190129269@qq.com China 9136 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627
 customer_service@efebio.com China 11974 58
  • FABACEIN
  • (10α,23E)-16α,25-Diacetoxy-2β,20-dihydroxy-9β-methyl-19-norlanosta-5,23-diene-3,11,22-trione
  • 19-Norlanosta-5,23-diene-3,11,22-trione, 16,25-bis(acetyloxy)-2,20-dihydroxy-9-methyl-, (2β,9β,10α,16α,23E)- (9CI)
  • 19-Norlanosta-5,23-diene-3,11,22-trione, 16,25-bis(acetyloxy)-2,20-dihydroxy-9-methyl-, (2β,9β,10α,16α,23E)-
  • 37710-13-7
Copyright 2019 ? ChemicalBook. All rights reserved